Advertisement

Women and Excessive Daytime Sleepiness

  • Hrayr P. Attarian
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

This chapter discusses excessive daytime sleepiness (EDS) related to primary sleep disorders other than obstructive sleep apnea syndrome (OSAS) and restless legs syndrome (RLS) and EDS secondary to other medical problems-the secondary hypersomnias.

Keywords

Sleep Disorder Obstructive Sleep Apnea Syndrome Epworth Sleepiness Scale Excessive Daytime Sleepiness Human Leukocyte Antigen Class 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Liu, X., M. Uchiyama, K. Kim, et al., Sleep loss and daytime sleepiness in the general adult population of Japan. Psychiatry Res, 2000;93(1):1–11.PubMedCrossRefGoogle Scholar
  2. 2.
    Doi, Y. and M. Minowa, Gender differences in excessive daytime sleepiness among Japanese workers. Soc Sci Med, bd2003];56(4):883–894.PubMedCrossRefGoogle Scholar
  3. 3.
    Lichstein, K.L., H.H. Durrence, B.W. Riedel, D.J. Taylor, and A.J. Bush, Epidemiology of Sleep. Mahwah, NJ: Lawrence Erlbaum Associates, 2004:238.Google Scholar
  4. 4.
    Johns, M. and B. Hocking, Daytime sleepiness and sleep habits of Australian workers. Sleep, 1997;20(10):844–849.PubMedGoogle Scholar
  5. 5.
    Baldwin, C.M., V.K. Kapur, C.J. Holberg, C. Rosen, and F.J. Nieto, Associations between gender and measures of daytime somnolence in the Sleep Heart Health Study. Sleep, 2004;27(2):305–311.PubMedGoogle Scholar
  6. 6.
    Liu, X., Z. Sun, M. Uchiyama, K. Shibui, K. Kim, and M. Okawa, Prevalence and correlates of sleep problems in Chinese schoolchildren. Sleep, 2000;23(8):1053–1062.PubMedGoogle Scholar
  7. 7.
    Doghramji, K., M.M. Mitler, R.B. Sangal, et al., A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr Clin Neurophysiol, 1997;103(5):554–562.PubMedCrossRefGoogle Scholar
  8. 8.
    Mitler, M.M., K. Doghramji, and C. Shapiro, The maintenance of wakefulness test: normative data by age. J Psychosom Res, 2000;49(5):363–365.PubMedCrossRefGoogle Scholar
  9. 9.
    American Academy of Sleep Medicine. The International Classification of Sleep Disorders, revised. Diagnostic and Coding Manual. Chicago: American Academy of Sleep Medicine, 2001.Google Scholar
  10. 10.
    Billiard, M., C. Guilleminault, and W.C. Dement, A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity? Neurology, 1975;25(5):436–443.PubMedGoogle Scholar
  11. 11.
    Papy, J.J., B. Conte-Devolx, J. Sormani, R. Porto, and V. Guillame, [The periodic hypersomnia and megaphagia syndrome in a young female, correlated with menstrual cycle (author’ transl)]. Rev Electroencephalogr Neurophysiol Clin, 1982;12(1):54–61.PubMedCrossRefGoogle Scholar
  12. 12.
    Sachs, C., H.E. Persson, and K. Hagenfeldt, Menstruation-related periodic hypersomnia: a case study with successful treatment. Neurology, 1982;32(12):1376–1379.PubMedGoogle Scholar
  13. 13.
    Bamford, C.R., Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. Sleep, 1993;16(5):484–486.PubMedGoogle Scholar
  14. 14.
    Manber, R. and R.R. Bootzin, Sleep and the menstrual cycle. Health Psychol, 1997;16(3):209–214.PubMedCrossRefGoogle Scholar
  15. 15.
    Lemire, I., [Review of Kleine-Levin syndrome: toward an integrated approach]. Can J Psychiatry, 1993;38(4):277–284.PubMedGoogle Scholar
  16. 16.
    Rosenow, F., P. Kotagal, B.H. Cohen, C. Green, and E. Wyllie, Multiple sleep latency test and polysomnography in diagnosing Kleine-Levin syndrome and periodic hypersomnia. J Clin Neurophysiol, 2000;17(5):519–522.PubMedCrossRefGoogle Scholar
  17. 17.
    Rye, D.B., B. Dihenia, J.D. Weissman, C.M. Epstein, and D.L. Bliwise, Presentation of narcolepsy after 40. Neurology, 1998;50(2):459–465.PubMedGoogle Scholar
  18. 18.
    Wise, M.S., Childhood narcolepsy. Neurology, 1998;50(2 Suppl 1):S37–S42.PubMedGoogle Scholar
  19. 19.
    Black, J.E., S.N. Brooks, and S. Nishino, Narcolepsy and syndromes of primary excessive daytime somnolence. Semin Neurol, 2004;24(3):271–282.PubMedCrossRefGoogle Scholar
  20. 20.
    Ellis, M.C., A.H. Hetisimer, D.A. Ruddy, et al., HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogenetics, 1997;46(5):410–417.PubMedCrossRefGoogle Scholar
  21. 21.
    Mignot, E., A. Kimura, A. Lattermann, et al., Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens, 1997;49(4):329–341.PubMedCrossRefGoogle Scholar
  22. 22.
    Sakurai, T., A. Amemiya, M. Ishii, et al., Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 1998;92(4):573–585.PubMedCrossRefGoogle Scholar
  23. 23.
    Kanbayashi, T., Y. Inoue, S. Chiba, et al., CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res, 2002;11(1):91–93.PubMedCrossRefGoogle Scholar
  24. 24.
    Lin, L., J. Faraco, R. Li, et al., The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 1999;98(3):365–376.PubMedCrossRefGoogle Scholar
  25. 25.
    Chemelli, R.M., J.T. Willie, C.M. Sinton, et al., Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 1999;98(4):437–451.PubMedCrossRefGoogle Scholar
  26. 26.
    Thannickal, T.C., R.Y. Moore, R. Nienhuis, et al., Reduced number of hypocretin neurons in human narcolepsy. Neuron, 2000;27(3):469–474.PubMedCrossRefGoogle Scholar
  27. 27.
    Nishino, S., B. Ripley, S. Overeem, G.J. Lammers, and E. Mignot, Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 2000;355(9197):39–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Khatami, R., S. Maret, E. Werth, et al., Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet, 2004;363(9416):1199–1200.PubMedCrossRefGoogle Scholar
  29. 29.
    Ohayon, M.M., M. Caulet, P. Philip, C. Guilleminault, and R.G Priest, How sleep and mental disorders are related to complaints of daytime sleepiness. Arch Intern Med, 1997;157(22):2645–2652.PubMedCrossRefGoogle Scholar
  30. 30.
    Thorpy, M.J., J.R. Schwartz, R. Kovacevic-Ristanovic, and R. Hayduk, Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies. Psychopharmacology (Berl), 2003;167(4):380–385.Google Scholar
  31. 31.
    Littner, M., S.F. Johnson, W.V. McCall, et al., Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep, 2001;24(4):451–466.PubMedGoogle Scholar
  32. 32.
    Akaoka, H., B. Roussel, J.S. Lin, G. Chouvet, and M. Jouvet, Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity. Neurosci Lett, 1991;123(1):20–22.PubMedCrossRefGoogle Scholar
  33. 33.
    Ferraro, L., T. Antonelli, W.T. O’Connor, S. Tanganelli, F.A. Rambert, and K. Fuxe, Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry, 1997;42(12):1181–1183.PubMedCrossRefGoogle Scholar
  34. 34.
    Engber, T.M., E.J. Koury, S.A. Dennis, M.S. Miller, C. Contreras, and R.V. Bhat, Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulnesspromoting agent modafinil. Neurosci Lett, 1998;241(2–3):95–98.PubMedCrossRefGoogle Scholar
  35. 35.
    Lin, J.S., Y. Hou, and M. Jouvet, Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA, 1996;93(24):14128–1433.PubMedCrossRefGoogle Scholar
  36. 36.
    Scammell, T.E., I.V. Estabrooke, M.T. McCarthy, et al., Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci, 2000;20(22):8620–8628.PubMedGoogle Scholar
  37. 37.
    U.S. Xyrem Multicenter Study Group, Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med, 2004;5(2):119–123.CrossRefGoogle Scholar
  38. 38.
    Scrima, L., P.G. Hartman, F.H. Johnson Jr., E.E. Thomas, and F.C. Hiller, The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Sleep, 1990;13(6):479–490.PubMedGoogle Scholar
  39. 39.
    Billiard, M. and Y. Dauvilliers, Idiopathic hypersomnia. Sleep Med Rev, 2001;5(5):349–358.PubMedCrossRefGoogle Scholar
  40. 40.
    Dauvilliers, Y., C.R. Baumann, B. Carlander, et al., CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry, 2003;74(12):1667–1673.PubMedCrossRefGoogle Scholar
  41. 41.
    Bassetti, C., M. Gugger, M. Bischof, et al., The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med, 2003;4(1):7–12.PubMedCrossRefGoogle Scholar
  42. 42.
    Bassetti, C. and M.S. Aldrich, Idiopathic hypersomnia. A series of 42 patients. Brain, 1997;120(Pt 8):1423–1435.PubMedCrossRefGoogle Scholar
  43. 43.
    Billiard, M., Idiopathic hypersomnia. Neurol Clin, 1996;14(3):573–582.PubMedCrossRefGoogle Scholar
  44. 44.
    Jameson, L.J. and A.P. Weetman, Disorders of the thyroid gland. In: Harrison’ Principles of Internal Medicine (D.L. Kasper, et al., eds.). Hightstown, NJ: McGraw-Hill, 2004:2104–2127.Google Scholar
  45. 45.
    Lin, C.C., K.W. Tsan, and P.J. Chen, The relationship between sleep apnea syndrome and hypothyroidism. Chest, 1992;102(6):1663–1667.PubMedCrossRefGoogle Scholar
  46. 46.
    Miller, C.M. and A.M. Husain, Should women with obstructive sleep apnea syndrome be screened for hypothyroidism? Sleep Breath, 2003;7(4):185–188.PubMedCrossRefGoogle Scholar
  47. 47.
    Skjodt, N.M., R. Atkar, and P.A. Easton, Screening for hypothyroidism in sleep apnea. Am J Respir Crit Care Med, 1999;160(2):732–735.PubMedGoogle Scholar
  48. 48.
    Khan, A.A., C.O. Gardner, C.A. Prescott, and K.S. Kendler, Gender differences in the symptoms of major depression in opposite-sex dizygotic twin pairs. Am J Psychiatry, 2002;159(8):1427–1429.PubMedCrossRefGoogle Scholar
  49. 49.
    Sadock, B.J. and V.A. Sadock, Mood disorders. In: Kaplan and Sadock’ Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry (B.J. Sadock and V.A. Sadock, eds.). Philadelphia: Lippincott Williams & Wilkins, 2002:534–572.Google Scholar
  50. 50.
    Vgontzas, A.N., E.O., Bixler, A. Kales, C. Criley, and A. Vela-Bueno, Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications. Psychosom Med, 2000;62(2):220–226.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • Hrayr P. Attarian
    • 1
  1. 1.Vermont Regional Sleep Center Department of NeurologyUniversity of Vermont College of Medicine/Fletcher Allen Health CareBurlington

Personalised recommendations